Ozempic and Irrationality in Medicine

GLP-1 receptor agonists like Ozempic have moved far beyond diabetes management — they are now reshaping how medicine, culture, and society understand body weight itself.But as these drugs become normalized, a deeper ethical question emerges: are we entering an era where body size becomes equated with rationality — and where those who do not conform are quietly pushed outside the boundaries of full credibility in healthcare?Join us as we explore the bioethics of GLP-1 medications, covering the fine line between medical optimization and conditional access to care, the rise of obligatory thinness as a medicalized moral expectation, and epistemic harm — how fat patients risk losing credibility, not just dignity, in clinical spaces.